The Cannabis Investing Podcast

Have cannabis investors been early or wrong or both?

Cannabis REITs: less risky choices in a risky sector

High Tide CEO Raj Grover on Germany, Canada and the U.S.

Green Thumb stands alone. Billions in debt coming for MSOs.

Cause for concern in cannabis with a few rays of light

Grown Rogue is focused on Jersey, yield, cost and culture

Why cannabis is still an excellent long-term investment opportunity

Ayr CEO David Goubert on Florida, Ohio and 'very balanced' Q2

Psychedelic stocks: focus on their cash

Cannabis investing in the age of legalization with Julian Lin, Tim Seymour and Pablo Zuanic

Cannabis investing masterclass with Julian Lin + Jerry Derevyanny

Looking for the Bud Light of cannabis

What has Verano so optimistic about the cannabis industry?

Mario Naric on Canada's shakeout phase

Cannabist CEO David Hart on breathtaking volatility and technical overhangs

How retail investors should evaluate cannabis stocks

An unvarnished look at New York + California cannabis markets

Alan Brochstein on rescheduling overexcitement, MSOs, Canada and the burden of 280E

De-risking psychedelics: Compass Pathways, Cybin and Atai

Investing In cannabis? Stay patient, be ready

Cannabis investors - what you should know

TerrAscend's Jason Wild: Not all EBITDA numbers are created equally

Cannabis ETF deep dive

Chris DeMuth talks cannabis, SAFE banking + SHF Holdings

Is it really time to be bullish on cannabis stocks?

Cannabis stocks have been rallying but when will capital flow into the industry?

Cannabis investing with Alan Brochstein & Julian Lin - REITs + Canadian LPs over MSOs

Virtual reality + psychedelic therapy

Texas cannabis, delta-8 and delta-9 with Paul Trowe

Psychedelic stocks = super-risky biotechs low on cash. Make small bets.

Psychedelics gaining acceptance; what does it mean for investors?

MariMed CEO Jon Levine: Cannabis industry still missing the real investments

Cultivating profitable cannabis

Not necessarily time to buy cannabis stocks - Alan Brochstein

4Front Ventures: Cash flow break-even probably the only KPI that matters

What will catalyze psychedelic stocks?

Tremendous opportunity in cannabis

Ayr Wellness CEO David Goubert Focused On Debt And Cash

Unpacking New York And California Cannabis Markets

Imran Khan On Psychedelics - More We Don't Know Than We Do

Where Is The Value In Cannabis Stocks?

Cannabis Is A Psychedelic - Dr. Julie Holland

Ascend's Attractive Assets

Pragmatic Cannabis Investing

Numinus CEO Payton Nyquvest On Transforming Healthcare With Psychedelics

Cannabis Investing Podcast Roundtable

Organigram CEO Beena Goldenberg - Expanding Beyond Canada

Looking For The Cheapest Cannabis Stocks

Psychedelic Sunday: Mushrooms Are The Key - Red Light Holland CEO Todd Shapiro

Wana Brands CEO Nancy Whiteman On Growth With Conviction